| AACE | American Association of Clinical Endocrinologists |
| ALF | Alfacalcidol |
| ALP | Alkaline phosphatase |
| AO | Antioxidants |
| ARED | Advanced resistive exercise device |
| BP | Bisphosphonate |
| BF | Bone formation |
| BL | Bone loss |
| BR/BRS | Bone resorption |
| BMD | Bone mineral density |
| BT | Bone turnover |
| bMSC | Bone mesenchymal stem cell |
| BV/TV | Bone volume fraction |
| CM | Countermeasure |
| CMS | Cyclic mechanical stretch treated bone mesenchymal stem cell-derived exosomes |
| DM | Differentiation marker |
| HLU | Hindlimb unloading |
| IL-6 mAb | Interleukin-6 monoclonal antibody |
| ISS | International Space Station |
| MP | Menopausal |
| OB | Osteoblast |
| OC | Osteoclast |
| OP | Osteoporosis |
| PC-I | Pan-caspase inhibitor |
| PI | Proteasome inhibitor |
| PMP | Postmenopausal |
| PTH | Parathyroid hormone |
| RANKL | Receptor activator of nuclear factor κβ ligand |
| RHLI | Right hindlimb immobilization |
| R-irisin | Recombinant irisin |
| SCHN | Strontium-containing hydroxyapatite nanoparticles |
| SERM | Selective estrogen receptor modulator |
| S-µg | Simulated microgravity |
| uCaV | Urinary calcium excretion |
| uNTx | Urinary N-telopeptide |
| Wnt | Wingless-related integration site |
| ZOL | Zoledronic acid |
| µg | Microgravity |